Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-21

Clinical Trial Update: Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria [Phase 1, Phase 2]

View source ↗

Summary

This document reports safety and efficacy findings from Phase 1/Phase 2 trials of the RTS,S AS02A/AS01B malaria vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mosquirix (RTS,S) malaria vaccine (RTS,S)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED